Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers

Altered myofibrillar structure is a consequence of dystrophic pathology that impairs skeletal muscle contractile function and increases susceptibility to contraction injury. In murine Duchenne muscular dystrophy (mdx), myofibrillar alterations are abundant in advanced pathology (>4 months), a...

Full description

Bibliographic Details
Main Authors: Anicca D. Harriot, Tessa Altair Morris, Camilo Vanegas, Jacob Kallenbach, Kaylie Pinto, Humberto C. Joca, Marie-Jo Moutin, Guoli Shi, Jeanine A. Ursitti, Anna Grosberg, Christopher W. Ward
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1209542/full
_version_ 1797737035791859712
author Anicca D. Harriot
Tessa Altair Morris
Camilo Vanegas
Jacob Kallenbach
Kaylie Pinto
Humberto C. Joca
Marie-Jo Moutin
Guoli Shi
Jeanine A. Ursitti
Anna Grosberg
Anna Grosberg
Anna Grosberg
Christopher W. Ward
Christopher W. Ward
author_facet Anicca D. Harriot
Tessa Altair Morris
Camilo Vanegas
Jacob Kallenbach
Kaylie Pinto
Humberto C. Joca
Marie-Jo Moutin
Guoli Shi
Jeanine A. Ursitti
Anna Grosberg
Anna Grosberg
Anna Grosberg
Christopher W. Ward
Christopher W. Ward
author_sort Anicca D. Harriot
collection DOAJ
description Altered myofibrillar structure is a consequence of dystrophic pathology that impairs skeletal muscle contractile function and increases susceptibility to contraction injury. In murine Duchenne muscular dystrophy (mdx), myofibrillar alterations are abundant in advanced pathology (>4 months), an age where we formerly established densified microtubule (MT) arrays enriched in detyrosinated (deTyr) tubulin as negative disease modifiers impacting cell mechanics and mechanotransduction. Given the essential role of deTyr-enriched MT arrays in myofibrillar growth, maintenance, and repair, we examined the increased abundance of these arrays as a potential mechanism for these myofibrillar alterations. Here we find an increase in deTyr-tubulin as an early event in dystrophic pathology (4 weeks) with no evidence myofibrillar alterations. At 16 weeks, we show deTyr-enriched MT arrays significantly densified and co-localized to areas of myofibrillar malformation. Profiling the enzyme complexes responsible for deTyr-tubulin, we identify vasohibin 2 (VASH2) and small vasohibin binding protein (SVBP) significantly elevated in the mdx muscle at 4 weeks. Using the genetic increase in VASH2/SVBP expression in 4 weeks wild-type mice we find densified deTyr-enriched MT arrays that co-segregate with myofibrillar malformations similar to those in the 16 weeks mdx. Given that no changes in sarcomere organization were identified in fibers expressing sfGFP as a control, we conclude that disease-dependent densification of deTyr-enriched MT arrays underscores the altered myofibrillar structure in dystrophic skeletal muscle fibers.
first_indexed 2024-03-12T13:22:34Z
format Article
id doaj.art-a51700562a7c4ab8a3cb96c40aeb52a0
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-03-12T13:22:34Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-a51700562a7c4ab8a3cb96c40aeb52a02023-08-25T16:54:41ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-08-011110.3389/fcell.2023.12095421209542Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibersAnicca D. Harriot0Tessa Altair Morris1Camilo Vanegas2Jacob Kallenbach3Kaylie Pinto4Humberto C. Joca5Marie-Jo Moutin6Guoli Shi7Jeanine A. Ursitti8Anna Grosberg9Anna Grosberg10Anna Grosberg11Christopher W. Ward12Christopher W. Ward13Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United StatesCenter for Complex Biological Systems, Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center, and the NSF-Simons Center for Multiscale Cell Fate Research, University of California, Irvine, Irvine, CA, United StatesDepartment of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United StatesINSERM U1216 Centre National de la Recherche Scientifique, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, FranceDepartment of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, United StatesCenter for Complex Biological Systems, Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center, and the NSF-Simons Center for Multiscale Cell Fate Research, University of California, Irvine, Irvine, CA, United StatesDepartment of Biomedical Engineering, Sue and Bill Gross Stem Cell Research, University of California, Irvine, Irvine, CA, United StatesDepartment of Chemical and Biomolecular Engineering, Sue and Bill Gross Stem Cell Research, University of California, Irvine, Irvine, CA, United StatesDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United StatesDepartment of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, United StatesAltered myofibrillar structure is a consequence of dystrophic pathology that impairs skeletal muscle contractile function and increases susceptibility to contraction injury. In murine Duchenne muscular dystrophy (mdx), myofibrillar alterations are abundant in advanced pathology (>4 months), an age where we formerly established densified microtubule (MT) arrays enriched in detyrosinated (deTyr) tubulin as negative disease modifiers impacting cell mechanics and mechanotransduction. Given the essential role of deTyr-enriched MT arrays in myofibrillar growth, maintenance, and repair, we examined the increased abundance of these arrays as a potential mechanism for these myofibrillar alterations. Here we find an increase in deTyr-tubulin as an early event in dystrophic pathology (4 weeks) with no evidence myofibrillar alterations. At 16 weeks, we show deTyr-enriched MT arrays significantly densified and co-localized to areas of myofibrillar malformation. Profiling the enzyme complexes responsible for deTyr-tubulin, we identify vasohibin 2 (VASH2) and small vasohibin binding protein (SVBP) significantly elevated in the mdx muscle at 4 weeks. Using the genetic increase in VASH2/SVBP expression in 4 weeks wild-type mice we find densified deTyr-enriched MT arrays that co-segregate with myofibrillar malformations similar to those in the 16 weeks mdx. Given that no changes in sarcomere organization were identified in fibers expressing sfGFP as a control, we conclude that disease-dependent densification of deTyr-enriched MT arrays underscores the altered myofibrillar structure in dystrophic skeletal muscle fibers.https://www.frontiersin.org/articles/10.3389/fcell.2023.1209542/fulldystrophyskeletal musclemyoarchitecturemicrotubule arraydetyrosination
spellingShingle Anicca D. Harriot
Tessa Altair Morris
Camilo Vanegas
Jacob Kallenbach
Kaylie Pinto
Humberto C. Joca
Marie-Jo Moutin
Guoli Shi
Jeanine A. Ursitti
Anna Grosberg
Anna Grosberg
Anna Grosberg
Christopher W. Ward
Christopher W. Ward
Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
Frontiers in Cell and Developmental Biology
dystrophy
skeletal muscle
myoarchitecture
microtubule array
detyrosination
title Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
title_full Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
title_fullStr Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
title_full_unstemmed Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
title_short Detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
title_sort detyrosinated microtubule arrays drive myofibrillar malformations in mdx muscle fibers
topic dystrophy
skeletal muscle
myoarchitecture
microtubule array
detyrosination
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1209542/full
work_keys_str_mv AT aniccadharriot detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT tessaaltairmorris detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT camilovanegas detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT jacobkallenbach detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT kayliepinto detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT humbertocjoca detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT mariejomoutin detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT guolishi detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT jeanineaursitti detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT annagrosberg detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT annagrosberg detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT annagrosberg detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT christopherwward detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers
AT christopherwward detyrosinatedmicrotubulearraysdrivemyofibrillarmalformationsinmdxmusclefibers